$SBC

SBC Medical Group Holdings (Nasdaq: SBC) reported Q2 FY2026 results for the three months ended June 30, 2026. Total revenue rose 13% to $49 million. Net income attributable to SBC Medical increased 335% to $11 million, with basic EPS of $0.10. Adjusted EBITDA rose 32% to $20 million. The company cited AI-enabled support and fee expansions, and said it has $184 million cash.

SBC Medical Group Holdings (Nasdaq: SBC) reported Q2 FY2026 results for the three months ended June 30, 2026. Total revenue rose 13% to $49 million. Net income attributable to SBC Medical increased 335% to $11 million, and Adjusted EBITDA rose 32% to $20 million. The company cited AI-enabled fee increases and expects about $15 million in annual service-fee gains if fully realized.

SBC Medical Group Holdings Inc (SBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sbc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Attributable to SBC Medical Up 335%, Adjusted EBITDA 1 Up 32% Year-over-Year.

SBC Medical Group Holdings Inc (SBC) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. EX-3.2 3 ex3-2.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF SBC MEDICAL GROUP HOLDINGS INCORPORATED Adopted: July 8, 2026 1. Offices . The address of the registered office of SBC Medical Group Holdings Incorporated (the “ Corporation ”) in the State of Delaware, and the

CIRO announced a trading halt for Brompton Split Banc Corp. (TSX: SBC). CIRO halted all issues due to pending news, with the halt starting at 3:16 PM ET on July 14, 2026. CIRO said halts are used to maintain fair and orderly markets while awaiting new information.

SBC Medical Group (NASDAQ:SBC) shareholders approved its director nominees and ratified MaloneBailey LLP as independent auditor for fiscal 2026. The charter was amended to remove plurality voting and “for cause” director removal, opt out of DGCL Section 203, and add officer exculpation, among other technical changes. Final results will be filed on Form 8-K.

SBC Medical Group Holdings (Nasdaq: SBC) said it will open SBC MEN'S FLASH CLINIC Ikebukuro in Tokyo on Aug. 6, 2026, focused on men's beard hair removal. The company says the format uses standardized, low-cost operations and is designed to scale across its clinic network. It cites ISAPS data showing men’s aesthetic procedures rose 6.3% in 2024. A six-session course is priced at 16,800 yen.

SBC Medical Group Holdings (Nasdaq: SBC) said it will participate in several investor conferences in May and June 2026, delivering webcast presentations and holding one-on-one meetings with institutional investors, according to the company. The update is relevant for traders tracking management outreach and potential investor sentiment ahead of upcoming events.

SBC Medical Group Holdings Inc. (NASDAQ: SBC) filed an amendment to its 2025 annual report, detailing director information, executive compensation, ownership structure, and related-party transactions, without altering financial results. The filing highlights CEO Yoshiyuki Aikawa's 81.7% voting control, making SBC a "controlled company" under Nasdaq rules. It also discloses significant related-party revenues from Japanese medical corporations tied to the CEO's family and the compensation structure for its executive officers and non-employee directors.

SBC Medical Group Holdings Inc.'s Chairman and CEO, Yoshiyuki Aikawa, sold 465,000 shares of common stock at $3.0225 per share on April 28, 2026. This transaction was part of the underwriters' option related to an underwritten public offering that closed on April 21, 2026. Despite the sale, Aikawa retains a substantial direct and indirect stake in the company, leading analysts to view this as a routine liquidity event rather than a significant change in his investment thesis.